NCT01819467 is a NA clinical trial of Seprafilm in Tissue Adhesions, sponsored by South East Area Health Education Center, Wilmington, NC.

Who is sponsoring NCT01819467?

NCT01819467 is sponsored by South East Area Health Education Center, Wilmington, NC.

What drugs are being tested in NCT01819467?

Interventions in NCT01819467: Seprafilm.

What condition does NCT01819467 study?

NCT01819467 studies Tissue Adhesions.

Is NCT01819467 still recruiting?

NCT01819467 is currently terminated. Last updated 24 July 2023.

Are results published for NCT01819467?

Yes — primary outcome results have been posted to ClinicalTrials.gov. See the outcomes section above for details.

Last reviewed 2023-07-24 · How we verify

NCT01819467

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

A Randomized Controlled Trial to Reduce Adhesions Following a Primary Cesarean Section

Terminated NA Results posted Last updated 24 July 2023

What this trial tests

NA trial testing Seprafilm in Tissue Adhesions in 29 participants. Terminated before completion.

Timeline

1 June 2014

Primary endpoint
1 September 2016

1 September 2016

Quick facts

Lead sponsor	South East Area Health Education Center, Wilmington, NC
Phase	NA
Status	Terminated
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	prevention
Enrollment	29
Start date	1 June 2014
Primary completion	1 September 2016
Estimated completion	1 September 2016
Sites	1 location across United States

Drugs / interventions tested

Seprafilm — full drug profile →

Conditions studied

Tissue Adhesions — all drugs for Tissue Adhesions →

Sponsor

South East Area Health Education Center, Wilmington, NC

Who can join

12 and older, female only, with Tissue Adhesions. Patients with the condition only — healthy volunteers not accepted.

What's being measured

Primary outcomes are the specific endpoints the trial is designed to prove or disprove.

Adhesion Formation Following a Primary C-section With and Without Adhesion Barrier
Time frame: 21 months
Study was terminated due to too many protocol deviations. There were no outcome measures analyzed.

Sponsor's own description

The primary objective of this study is to determine whether the use of Seprafilm reduces the incidence rate of adhesion formation following a primary C-section. A secondary objective of the study will be to determine whether or not a correlation between the adhesion score and the difficulty or delay in delivery of the infant exists.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other South East Area Health Education Center, Wilmington, NC trials

Trials by the same sponsor.

NCT03545503 — Evaluating the Hemodynamic Effects of Ketamine Versus Etomidate During Rapid Sequence Intubation · Phase 4 · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT01819467 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by South East Area Health Education Center, Wilmington, NC
Last refreshed: 24 July 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT01819467.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing